VFI supports Sars-Cov-2 vaccine development through TRANSVAC2 (European Commission)

As partner of TRANSVAC2, VFI offers its adjuvant and formulation services to vaccine researchers and developers in the context of Covid-19. Vaccine researchers and developers can ship their Sars-Cov-2 vaccine antigens to VFI for formulation with adjuvants suitable for clinical use. Once optimal formulations are identified, VFI can perform immunogenicity studies in mice including analyses of B- and T-cell …

read moreVFI supports Sars-Cov-2 vaccine development through TRANSVAC2 (European Commission)

VFI supports Sars-Cov-2 vaccine development through GH-VAP (Bill & Melinda Gates Foundation)

VFI is working with grantees from the Bill & Melinda Gates Foundation (BMGF) to evaluate Sars-Cov-2 vaccine candidates. Antigens provided by BMGF grantees are appropriately formulated with adjuvants developed by VFI with the ultimate goal to identify suitable Sars-Cov-2 vaccine candidates which can progress towards the clinic. This work is supported by the Global Health Vaccine …

read moreVFI supports Sars-Cov-2 vaccine development through GH-VAP (Bill & Melinda Gates Foundation)

VFI will actively support the development of vaccines against Covid-19

VFI will support the vaccine community during Covid-19 pandemic. VFI is currently manufacturing several adjuvants to be included in upcoming Covid-19 studies and has secured access to animal facilities for immunogenicity studies of adjuvanted-Sars-Cov-2 vaccine formulations. VFI is also setting up collaborations with numerous vaccine developers worldwide in order to formulate Sars-Cov-2 vaccine candidates with …

read moreVFI will actively support the development of vaccines against Covid-19

6th Call for TRANSVAC Vaccine Development Services (TNA)

Access to VFI’s Adjuvants and Formulation Services – free of charge. TRANSVAC project offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. Services are offered free of charge! Academic and non-academic research groups, SMEs and industries can apply but only to service infrastructures outside their …

read more6th Call for TRANSVAC Vaccine Development Services (TNA)

5th Call for TRANSVAC: European Training in Vaccinology – deadline for applications 1 July 2019

The fifth call is open until 1st July 2019. It covers 3 modules: M10 – Assay Development and Validation – Application of SPR Technologies in Vaccine Development and Manufacturing conducted at Fraunhofer IME, Aachen Germany (10-11 October 2019) M11 – Process Development and scale-up of recombinant protein vaccines organized also by Fraunhofer IME, Aachen Germany (7-8 October …

read more5th Call for TRANSVAC: European Training in Vaccinology – deadline for applications 1 July 2019

4th Call for TRANSVAC: European Training in Vaccinology – deadline for applications 1 June 2019

The fourth call is open from 1 April 2019 – 1st June 2019. It covers 3 modules: M6 – CyTOF (Cytometry by time‐of‐flight) conducted at CEA, Fontenay-aux-Roses, France (19-20 September 2019) M7 – Flow Cytometry organized also by CEA, Fontenay-aux-Roses, France (18-19 September 2019) M9 – Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies, organized …

read more4th Call for TRANSVAC: European Training in Vaccinology – deadline for applications 1 June 2019